Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:20 pm Purchase | 13G | Replimune Group Inc. REPL | BAKER BROS. ADVISORS LP | 11,045,336 16.200% | 1,500,000 (+15.71%) | View |
| 2024-11-14 1:22 pm Purchase | 13G | Replimune Group Inc. REPL | PRICE T ROWE ASSOCIATES INC | 9,879,250 14.500% | 3,330,320 (+50.85%) | View |
| 2024-11-14 08:35 am Sale | 13G | Replimune Group Inc. REPL | Omega Fund IV L.P. | 2,709,991 4.000% | -540,000 (-16.62%) | View |
| 2024-11-14 07:00 am Sale | 13G | Replimune Group Inc. REPL | Forbion Capital Fund III Cooperatief U.A. | 5,115,121 7.500% | -76,500 (-1.47%) | View |
| 2024-11-12 4:51 pm Unchanged | 13G | Replimune Group Inc. REPL | VANGUARD GROUP INC | 3,466,247 5.070% | 0 (Unchanged) | View |
| 2024-11-04 1:53 pm Purchase | 13G | Replimune Group Inc. REPL | VANGUARD GROUP INC | 3,466,247 5.070% | 3,466,247 (New Position) | View |
| 2024-10-07 4:38 pm Sale | 13G | Replimune Group Inc. REPL | MORGAN STANLEY MS | 1,542,884 2.300% | -2,846,004 (-64.85%) | View |
| 2024-07-10 06:44 am Sale | 13G | Replimune Group Inc. REPL | STATE STREET CORP STT | 1,157,861 1.730% | -5,328,835 (-82.15%) | View |
| 2024-04-10 12:58 pm Purchase | 13G | Replimune Group Inc. REPL | PRICE T ROWE ASSOCIATES INC | 6,548,930 10.700% | 693,305 (+11.84%) | View |
| 2024-04-10 09:48 am Purchase | 13G | Replimune Group Inc. REPL | STATE STREET CORP STT | 6,486,696 10.570% | 1,375,175 (+26.90%) | View |
| 2024-02-14 4:44 pm Sale | 13G | Replimune Group Inc. REPL | Omega Fund IV L.P. | 3,249,991 5.500% | -360,487 (-9.98%) | View |
| 2024-02-14 4:26 pm Sale | 13G | Replimune Group Inc. REPL | Redmile Group LLC | 4,604,483 7.400% | -1,135,616 (-19.78%) | View |
| 2024-02-14 10:03 am Purchase | 13G | Replimune Group Inc. REPL | PRICE T ROWE ASSOCIATES INC | 5,855,625 9.900% | 790,881 (+15.62%) | View |
| 2024-02-14 07:21 am Purchase | 13G | Replimune Group Inc. REPL | Forbion Capital Fund III Cooperatief U.A. | 5,191,621 8.700% | 76,500 (+1.50%) | View |
| 2024-02-09 12:09 pm Purchase | 13G | Replimune Group Inc. REPL | MORGAN STANLEY MS | 4,388,888 7.400% | 4,388,888 (New Position) | View |
| 2024-01-26 11:49 am Purchase | 13G | Replimune Group Inc. REPL | BlackRock Inc. BLK | 4,538,487 7.700% | 1,527,935 (+50.75%) | View |
| 2024-01-25 06:58 am Purchase | 13G | Replimune Group Inc. REPL | STATE STREET CORP STT | 5,111,521 8.650% | 5,111,521 (New Position) | View |
| 2024-01-10 4:57 pm Purchase | 13G | Replimune Group Inc. REPL | BAKER BROS. ADVISORS LP | 9,545,336 16.200% | 3,777,109 (+65.48%) | View |
| 2023-02-14 4:22 pm Purchase | 13G | Replimune Group Inc. REPL | Redmile Group LLC | 5,740,099 9.900% | 574,968 (+11.13%) | View |
| 2023-02-14 4:00 pm Purchase | 13G | Replimune Group Inc. REPL | BAKER BROS. ADVISORS LP | 5,768,227 9.990% | 5,768,227 (New Position) | View |